U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula 2C21H29N6O5P.C4H4O4
Molecular Weight 1069.004
Optical Activity UNSPECIFIED
Defined Stereocenters 6 / 6
E/Z Centers 1
Charge 0

SHOW SMILES / InChI
Structure of TENOFOVIR ALAFENAMIDE FUMARATE

SMILES

OC(=O)\C=C\C(O)=O.CC(C)OC(=O)[C@H](C)N[P@](=O)(CO[C@H](C)CN1C=NC2=C(N)N=CN=C12)OC3=CC=CC=C3.CC(C)OC(=O)[C@H](C)N[P@](=O)(CO[C@H](C)CN4C=NC5=C(N)N=CN=C45)OC6=CC=CC=C6

InChI

InChIKey=SVUJNSGGPUCLQZ-FQQAACOVSA-N
InChI=1S/2C21H29N6O5P.C4H4O4/c2*1-14(2)31-21(28)16(4)26-33(29,32-17-8-6-5-7-9-17)13-30-15(3)10-27-12-25-18-19(22)23-11-24-20(18)27;5-3(6)1-2-4(7)8/h2*5-9,11-12,14-16H,10,13H2,1-4H3,(H,26,29)(H2,22,23,24);1-2H,(H,5,6)(H,7,8)/b;;2-1+/t2*15-,16+,33+;/m11./s1

HIDE SMILES / InChI

Molecular Formula C4H4O4
Molecular Weight 116.0722
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 1
Optical Activity NONE

Molecular Formula C21H29N6O5P
Molecular Weight 476.4659
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 3 / 3
E/Z Centers 0
Optical Activity UNSPECIFIED

Description
Curator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/20439609 and http://ir.chimerix.com/releasedetail.cfm?releaseid=752310

CMX157 is a lipid (1-0-hexadecyloxypropyl) conjugate of the acyclic nucleotide analog tenofovir (TFV) with activity against both wild-type and antiretroviral drug-resistant HIV strains, including multidrug nucleoside/nucleotide analog-resistant viruses. CMX157 was designed to mimic lysophosphatidylcholine to take advantage of natural lipid uptake pathways and to achieve high intracellular concentrations of the active antiviral, with the aim of increasing the effectiveness of TFV against wild-type and mutant HIV. CMX157 demonstrated potential to effectively suppress replication of multiNRTI-resistant (MNR) HIV that cannot be treated with any currently available NRTIs, including TDF. It is in phase II clinical trial for HIV infections in USA and phase Ib portion of the phase I/II trial for Hepatitis B in Thailand (PO).

Originator

Curator's Comment: reference retrieved from http://www.sciencedirect.com/science/article/pii/S2211383512001402

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
58.0 µM [Kd]
3.3 nM [EC50]
3.5 nM [EC50]
0.49 µM [EC50]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
VIREAD

Approved Use

Tenofovir disoproxil fumarate is a prescription medicine approved by the U.S. Food and Drug Administration (FDA) for the treatment of HIV and HBV infections

Launch Date

1.32675836E12
Primary
VIREAD

Approved Use

Tenofovir disoproxil fumarate is a prescription medicine approved by the U.S. Food and Drug Administration (FDA) for the treatment of HIV and HBV infections

Launch Date

1.32675836E12
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
Sourcing

Sourcing

Vendor/AggregatorIDURL
PubMed

PubMed

TitleDatePubMed
Differential antiherpesvirus and antiretrovirus effects of the (S) and (R) enantiomers of acyclic nucleoside phosphonates: potent and selective in vitro and in vivo antiretrovirus activities of (R)-9-(2-phosphonomethoxypropyl)-2,6-diaminopurine.
1993 Feb
Patents

Sample Use Guides

The recommended dose of Ictady (tenofovir disoproxil succinate) for the treatment of HIV or for the treatment of chronic hepatitis B is 245 mg (one tablet) once daily taken orally with food.
Route of Administration: Oral
In Vitro Use Guide
(R)-9-(2-Phosphonylmethoxypropyl)adenine (PMPA known as tenofovir) exerts antiretrovirus activity in MT-4 cells infected with HIV-1 and HIV-2 with EC50 values of 5.9 and 4.9 uM, respectively
Substance Class Chemical
Created
by admin
on Sat Dec 16 04:58:45 UTC 2023
Edited
by admin
on Sat Dec 16 04:58:45 UTC 2023
Record UNII
FWF6Q91TZO
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
TENOFOVIR ALAFENAMIDE FUMARATE
USAN   WHO-DD  
USAN  
Official Name English
ODEFSEY COMPONENT TENOFOVIR ALAFENAMIDE FUMARATE
Brand Name English
TENOFOVIR ALAFENAMIDE FUMARATE COMPONENT OF BIKTARVY
Brand Name English
GS-7340 HEMIFUMARATE
Code English
GS-7340-03
Code English
Tenofovir alafenamide fumarate [WHO-DD]
Common Name English
TENOFOVIR ALAFENAMIDE FUMARATE (2:1)
Common Name English
SYMTUZA COMPONENT TENOFOVIR ALAFENAMIDE FUMARATE
Brand Name English
TENOFOVIR ALAFENAMIDE FUMARATE COMPONENT OF SYMTUZA
Brand Name English
DESCOVY COMPONENT TENOFOVIR ALAFENAMIDE FUMARATE
Brand Name English
VEMLIDY
Brand Name English
1-METHYLETHYL N-((S)-(((1R)-2-(6-AMINO-9H-PURIN-9-YL)-1-METHYLETHOXY)METHYL(PHENOXYPHOSPHINOYL)-L-ALANINATE, (2E)-2-BUTENEDIOATE
Common Name English
TAF
Common Name English
TENOFOVIR ALAFENAMIDE HEMIFUMARATE
Common Name English
L-ALANINE, N-((S)-(((1R)-2-(6-AMINO-9H-PURIN-9-YL)-1-METHYLETHOXY)METHYL)PHENOXYPHOSPHINYL)-, 1-METHYLETHYL ESTER, (2E)-2-BUTENEDIOATE (2:1)
Common Name English
TENOFOVIR ALAFENAMIDE FUMARATE COMPONENT OF ODEFSEY
Brand Name English
TENOFOVIR ALAFENAMIDE FUMARATE [ORANGE BOOK]
Common Name English
TENOFOVIR ALAFENAMIDE FUMARATE [USAN]
Common Name English
TENOFOVIR ALAFENAMIDE FUMARATE [MI]
Common Name English
TENOFOVIR ALAFENAMIDE FUMARATE COMPONENT OF GENVOYA
Brand Name English
BIKTARVY COMPONENT TENOFOVIR ALAFENAMIDE FUMARATE
Brand Name English
TENOFOVIR ALAFENAMIDE FUMARATE COMPONENT OF DESCOVY
Brand Name English
TENOFOVIR ALAFENAMIDE FUMARATE [JAN]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C281
Created by admin on Sat Dec 16 04:58:45 UTC 2023 , Edited by admin on Sat Dec 16 04:58:45 UTC 2023
NCI_THESAURUS C97452
Created by admin on Sat Dec 16 04:58:45 UTC 2023 , Edited by admin on Sat Dec 16 04:58:45 UTC 2023
Code System Code Type Description
PUBCHEM
71492247
Created by admin on Sat Dec 16 04:58:45 UTC 2023 , Edited by admin on Sat Dec 16 04:58:45 UTC 2023
PRIMARY
MERCK INDEX
m12126
Created by admin on Sat Dec 16 04:58:45 UTC 2023 , Edited by admin on Sat Dec 16 04:58:45 UTC 2023
PRIMARY
NCI_THESAURUS
C152559
Created by admin on Sat Dec 16 04:58:45 UTC 2023 , Edited by admin on Sat Dec 16 04:58:45 UTC 2023
PRIMARY
SMS_ID
100000164069
Created by admin on Sat Dec 16 04:58:45 UTC 2023 , Edited by admin on Sat Dec 16 04:58:45 UTC 2023
PRIMARY
ChEMBL
CHEMBL2107825
Created by admin on Sat Dec 16 04:58:45 UTC 2023 , Edited by admin on Sat Dec 16 04:58:45 UTC 2023
PRIMARY
EVMPD
SUB178389
Created by admin on Sat Dec 16 04:58:45 UTC 2023 , Edited by admin on Sat Dec 16 04:58:45 UTC 2023
PRIMARY
FDA UNII
FWF6Q91TZO
Created by admin on Sat Dec 16 04:58:45 UTC 2023 , Edited by admin on Sat Dec 16 04:58:45 UTC 2023
PRIMARY
DAILYMED
FWF6Q91TZO
Created by admin on Sat Dec 16 04:58:45 UTC 2023 , Edited by admin on Sat Dec 16 04:58:45 UTC 2023
PRIMARY
CAS
1392275-56-7
Created by admin on Sat Dec 16 04:58:45 UTC 2023 , Edited by admin on Sat Dec 16 04:58:45 UTC 2023
PRIMARY
EPA CompTox
DTXSID401027740
Created by admin on Sat Dec 16 04:58:45 UTC 2023 , Edited by admin on Sat Dec 16 04:58:45 UTC 2023
PRIMARY
DRUG BANK
DBSALT002533
Created by admin on Sat Dec 16 04:58:45 UTC 2023 , Edited by admin on Sat Dec 16 04:58:45 UTC 2023
PRIMARY
WIKIPEDIA
TENOFOVIR ALAFENAMIDE FUMARATE
Created by admin on Sat Dec 16 04:58:45 UTC 2023 , Edited by admin on Sat Dec 16 04:58:45 UTC 2023
PRIMARY
RXCUI
1721604
Created by admin on Sat Dec 16 04:58:45 UTC 2023 , Edited by admin on Sat Dec 16 04:58:45 UTC 2023
PRIMARY RxNorm
USAN
AB-40
Created by admin on Sat Dec 16 04:58:45 UTC 2023 , Edited by admin on Sat Dec 16 04:58:45 UTC 2023
PRIMARY
CHEBI
90923
Created by admin on Sat Dec 16 04:58:45 UTC 2023 , Edited by admin on Sat Dec 16 04:58:45 UTC 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
Related Record Type Details
IMPURITY -> PARENT
Related Record Type Details
ACTIVE MOIETY